New Study Reveals How Plasmalogens Enhance NK Cell Function and Combat Age-Related Immune Decline. A groundbreaking study published in The Journal of Immunology has identified plasmalogens, specialized phospholipids that decrease with age,
as crucial regulators of natural killer (NK) cell activity. Researchers discovered that plasmalogens activate the GPCR21 receptor on NK cells, triggering a signaling cascade that increases the production of Perforin-1, a key protein that
enables NK cells to effectively target and destroy cancer cells. Additionally, oral supplementation of plasmalogens in mice was shown to inhibit tumor growth and prevent the spread of viral infections. These findings suggest that maintaining
plasmalogen levels could be vital for preserving immune function and protecting against infections and cancer in the elderly, offering promising avenues for addressing age-related immune deficiencies.
Reference: Hossain, M. S., Mawatari, S., & Fujino,
T. (2022). Plasmalogen-Mediated Activation of GPCR21 Regulates Cytolytic Activity of NK Cells against the Target Cells. The Journal of Immunology, 209, 310–325.
Plasmalogens (Pls), the unsung heroes of brain health, have been found to unlock the secrets of sharper memory and enhanced learning. These remarkable glycerophospholipids ignite brain-derived neurotrophic factor (BDNF) production in the hippocampus, fueling neurogenesis and supercharging cognitive abilities. By activating the ERK-Akt signaling pathways, Pls help recruit CREB transcription factors to key memory genes, strengthening synaptic connections and boosting long-term memory. A decline in Pls is linked to memory loss, making them a promising frontier for combating cognitive decline and enhancing brainpower naturally.
Reference: Hossain, M. S., Mawatari, S., & Fujino, T. (2022). Plasmalogens, the Vinyl Ether-Linked Glycerophospholipids, Enhance Learning and Memory by Regulating Brain-Derived Neurotrophic Factor. Frontiers in Cell and Developmental Biology, 10, Article 828282. https://doi.org/10.3389/fcell.2022.828282.
Download PDFBreakthrough Study Reveals KIT-13 as a Promising Neuroprotective Agent. A groundbreaking study highlights the potential of KIT-13, a novel plasmalogen derivative, in combating cognitive decline and neuroinflammation. KIT-13 significantly enhances memory, reduces neuroinflammation, and stimulates brain-derived neurotrophic factor (BDNF) production, surpassing the efficacy of natural plasmalogens. In mice, KIT-13 improved learning and memory, reduced amyloid beta accumulation, and inhibited neuronal apoptosis. This innovative compound also demonstrated robust neurogenesis and anti-inflammatory effects, positioning it as a potential therapeutic for neurodegenerative diseases like Alzheimer’s. KIT-13 offers a promising path forward in addressing cognitive impairment and age-related brain health challenges.
Reference: Hossain, M. S., Mawatari, S., Honsho, M., Okauchi, T., & Fujino, T. (2024). KIT-13, a novel plasmalogen derivative, attenuates neuroinflammation and amplifies cognition. Frontiers in Cell and Developmental Biology, 12, Article 1443536. https://doi.org/10.3389/fcell.2024.1443536
Download PDFAn advanced tool for RNASeq and transcriptomics data analysis.
A GUI-based software for analyzing and plotting genomic data.
Advanced software to automate mutation analysis in whole Genome of mice, humans, and C. elegans.
DownloadInteractive software for visualizing Signaling Pathways derived from RNASeq Analysis.
DownloadAdvanced tool for tracking and analyzing animal behavior patterns.
C. elegans tracking software for identifying precise changes in movement.
Download